The key is for drugmakers to work with the intent of outpacing the spread of the drug-resistant strains of the infection to stay ahead of consequences, which could entail getting set “back to the pre-antibiotic era,” Jeffrey Klausner, MD, a professor of medicine and public health at the University of Southern California told Bloomberg.
Gonorrhea specifically is more prone to becoming drug-resistant than other sexually transmitted infections because as cases have gone up in recent years after a long stretch of falling, “a rise in overall infections gives it more chances to adapt,” according to Bloomberg.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
